|
Debut Thriller Novel, Project Suicide, by John Bukowski, Turns Alzheimer's Cure into Political Assassin's Ideal Weapon
Wednesday, May 25, 2022
COLUMBUS, Ind., May 17, 2022 /PRNewswire/ -- PathBinder Publishing in Columbus, Indiana, has announced the release of a debut novel by one of its most recent discoveries, author John Bukowski. His suspenseful political thriller, Project Suicide, takes readers on a mind-bending ride as a long-awaited cure for Alzheimer's disease is perverted into a political assassin's ideal weapon. With a master's degree in public health, a veterinary degree, and a doctorate in epidemiology, Bukowski draws from his scientific expertise to bring a unique authenticity to this exhilarating novel. Project Suicide is available in hardback, paperback, and for Kindle devices online at www.projectsuicidenovel.com or ask for it where books are sold.
In Project Suicide, a string of high-profile politicians has strangely died by their own hand. Not aged bureaucrats breaking under the strain of political baggage but rising stars with stress and scandal still ahead of them - and more are likely. Only genius scientist Deacon Creel knows how to save them but there's a problem. Now he prefers the bottle to the test tube and the gutter to the laboratory. Although tormented by guilt for his part in releasing a weaponized Alzheimer's cure, Creel eventually agrees to pursue the antidote. While he and the few he can trust race to an antidote, they are hunted by sinister forces bent on government manipulation and power.
His main interest in writing this book was the enjoyment of his readers. "First and foremost, I hope that readers are entertained," Bukowski said. "Secondly, I hope they learn something; be that an interesting technical detail or the need for balance between logic and emotion as we live our lives."
Bukowski is an accomplished fiction and non-fiction writer published in numerous notable short story publications including, Dark Secrets, Makarelle, and Land Beyond the World. He has written hundreds of medical publications, from handbooks to websites, as well as radio scripts, and translations of technical topics for the general public.
A native of Detroit, Bukowski earned a master's degree in public health from the University of Michigan, a veterinary degree from Michigan State University, and a doctorate in epidemiology from the University of Medicine and Dentistry of New Jersey. After 15 years in Dayton, Ohio, John moved to the mountains of eastern Tennessee where he continues to write and enjoy his hobbies including acting on stage, singing, and volunteering at a local animal shelter.
Taking on a debut novel can be challenging for a publisher of any size, but PathBinder Publishing found Bukowski's work both original and engaging. "John successfully blends technical detail with the personal challenges faced by sympathetic characters, helping the reader to understand them," said Paul Hoffman, of PathBinder Publishing. "His idea for making a miracle drug's side effect into the perfect tool for an assassin is realistic and causes readers to consider what undiscovered consequences might lurk elsewhere. A great job on a debut novel."
Other authors are weighing in on Bukowski's work as well. Larry D. Sweazy, award-winning author of The Broken Bow, noted, "John Bukowski's debut thriller, Project Suicide, keeps you on the edge of your seat. I can't wait to read his next book!" Matthew Clemens, co-author of the Reeder and Rogers thrillers calls Project Suicide a, "rollercoaster ride filled with unforeseen twists, dips, and dives, right up to its stunning climax."
To contact the author, please call 937-439-0392 or email 336530@email4pr.com. For book sales information, contact Paul Hoffman at PathBinder Publishing, 317-407-4875 or paul@pathbinderpublishing.com or order through Ingram.
View original content to download multimedia:https://www.prnewswire.com/news-releases/debut-thriller-novel-project-suicide-by-john-bukowski-turns-alzheimers-cure-into-political-assassins-ideal-weapon-301548236.html
SOURCE John Bukowski
|
|
|
|
|
|
 |
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
|
|
AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
|
|
Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
|
|
Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
|
|
Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
|
|
Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
|
|
PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
|
|
TSX Venture Exchange Market Data Now Available Across Over 40 Blockchains via Chainlink | Jan 22, 2026
|
|
Young Adult Sports Fiction Debut Featured in LibraryBub Selection for January | Jan 22, 2026
|
|
IoTeX Publishes MiCA-Compliant Whitepaper for IOTX, Enabling EU-Wide Alignment Under the New Regulatory Framework | Jan 22, 2026
|
|
|
|
